Brief: Pharma Equity Net Loss For Year Widens To DKK 24.6 Mln

Pharma Equity A/S

20/03/2024 10:10

March 20 (Reuters) - Pharma Equity Group A/S  PEGRP.CO :
    * NET RESULT FOR YEAR WAS DKK -24.6 MILLION (2022: DKK -9.4
MILLION)
    * RESULT NEGATIVELY IMPACTED BY DOWNWARD REVISION OF DKK 4.4
MILLION OF VALUE ADJUSTMENT ETC. OF RECEIVABLE FROM SALE OF
PORTINHO S.A.
    * RESULT FOR YEAR IS AFFECTED BY RESEARCH AND DEVELOPMENT
COSTS OF
DKK 9.1 MILLION AND ADMINISTRATIVE EXPENSES OF DKK 11.9 MILLION
    * IN 2024, GROUP WILL FOCUS ON CREATING A SOLID FOUNDATION
FOR
REVENUE-GENERATING ACTIVITIES IN 2025 AND BEYOND
    * FOR 2024, CONSOLIDATED NET RESULT BEFORE TAX OF DKK -24 TO
-29
MILLION IS EXPECTED

Source text for Eikon:  ID:nGNE1dbqHm 
Further company coverage:  PEGRP.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))